**Subject:** Notice Regarding Online Registration for SUGAM Portal for CDSCO Services
This notice from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, announces the mandatory online registration process through the SUGAM portal for availing CDSCO services. Effective from 26.09.2018, physical applications will no longer be accepted. All stakeholders are required to register on the SUGAM portal to access CDSCO related services. For further information, contact Dr. S. Eswara Reddy, Drugs Controller General of India. Copies of this notice have been distributed to various divisions and officers within the CDSCO, as well as to relevant departments within the Ministry of Health & Family Welfare. The notice is also available on the CDSCO website.
Key Entities Referenced
Ministry of Health Family Welfare: A department of the Government of India responsible for health policy.
Directorate General of Health Services: An attached office of the Ministry of Health and Family Welfare, Government of India.
Central Drugs Standard Control Organisation: National Regulatory Authority (NRA) of India, under the Ministry of Health & Family Welfare, responsible for regulation of pharmaceuticals and medical devices.
FDA Bhawan, New Delhi: The location of Central Drugs Standard Control Organisation office.
Drugs Controller General India: The head of the Central Drugs Standard Control Organisation (CDSCO) in India.
Dr. S. Eswara Reddy: The Drugs Controller General of India.
MoHFW: Abbreviation for Ministry of Health and Family Welfare.
CDAC: Centre for Development of Advanced Computing. CDAC is involved in IT and Electronics.
Government
of India
Ministry of Health & Family Welfare
Directorate
General of Health Services
Central Drugs Standard Control Organisation
FDA Bhawan, New Delhi
Date:
ra
~ J
NOTICE
b(i ewm iwp nwl g.e cm rde oT sn lh lcte eoa
d
t o i n oC o l ue n tin nt ier n. a o
p
l gf
h
o avD s.r i ee nu s- )g
.
Gs o o v nS e t r 1a n 4n a .d n 1a c 1r e .d 2 0 C ho 1an 5t s .r o Vl a l raO iur ong uca shn i e sz d ea rt vi io a cn n e s ( rC O enD nlS i dC n eeO r e) d pi o bn r yt ap l Cu r Ds Su ' Ca Sn U Oc G e A
a
M rt ' eo
Sbit l Uois Go d Ad e MpcI r n i o pd ot de rh u tde c
a
t ltl .sha t a we t is lt f l rp boh ema s a2e c6, c. e0m p9o t.d e2u d0l .1 e 8
A
lf lno r o
t
B hp el h o y ao s pd i
p
c lP a ir l
c
o ad a tpu ipc olt nis sc aw sti hl il oo n ub le f
d
o l r
b
a eRu e n g mc i ah s ne t dd ra
a
to tin oo rn2
y
6 a. fn0 id l9
e
. dI 2 m t0 p h1 o r8 r
o
ta
u
gn o hd f
this
faciT lih tye
.
s Tt ha ek e ph ro old ce er ss s, ow
f
h ro
eg
ih sa tv rae
t
in oo nt ir
s
e pg ri ost ve ir de ed d, ofi nr st
t
hn ee hed
o
mt eo pr aeg gi es t oe fr Son
U
GS AU MG .AM to avail
A
x
(Dr. S. Eswara Reddy)
Drugs Controller General (India)
To
All Stake holders concerned
Copy to
1. All JDC (1), DDC (1), ADC (I) and Di s of Biological Division
2. PPS to AS & DG, MoHFW
3. PPS to JS (R), MoHFW
4. CDAC
5. Guard File
6. Website